ATXS – astria therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN
Astria Therapeutics: Updating Target Price, Biocryst Deal Expected To Go Through, Hold [Seeking Alpha]
Astria Therapeutics (NASDAQ:ATXS) was downgraded by analysts at Lifesci Capital from a "strong-buy" rating to a "hold" rating.
Why Analysts Say the BioCryst Story Is Changing After Astria Therapeutics Acquisition [Yahoo! Finance]
Form 425 Astria Therapeutics, Filed by: BIOCRYST PHARMACEUTICALS INC
Form SCHEDULE 13G/A Astria Therapeutics, Filed by: Vestal Point Capital, LP
Form SCHEDULE 13G/A Astria Therapeutics, Filed by: ForGrowth III PA B.V.
Form 10-Q Astria Therapeutics, For: Sep 30
Form 8-K Astria Therapeutics, For: Nov 12
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.